Professional Documents
Culture Documents
AND
ANTIFUNGAL
RE-ARRANGED BY
EKO S. PRIBADI
• Keratinases
1Pfaller,
M.A and Diekema, DJ. 2007. Epidemiology of Invasive Candidiasis: a Persistent Public
Health Problems. Clin. Microbiol. Rev., 20(1): 133–163.
MYCOSES CASES
1) USING IMMUNOSUPPRESIVE
DRUGS
2) PATIENTS OF AUTOIMMUNE
DISEASES
3) PATIENT OF CANCER
1Murphy, JW. 1993. Fungal Infections and Immune Responses. Murphy, JW. et al. (edit.). Plenum Press, NY.
FUNGI
1) WALL CELLS: CHITIN, GLUCAN, MANNAN
AND PEPTIDOGLICAN
1Murphy, JW. 1993. Fungal Infections and Immune Responses. Murphy, JW. et al. (edit.). Plenum Press, NY.
Referensi:
Cutler, JE. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45: 187-281
1Brawner, D. L., and J. E. Cutler. 1986. Variability in expression of cell surface antigens of Candida albicans during
morphogenesis. Infect. Immun. 51:337–343.
2Mayer, C. L., R. D. Diamond, and J. E. Edwards, Jr. 1990. Recognition of binding sites on Candida albicans by monoclonal
ALERGY
MYCOTOXICOSES
1Murphy, JW. 1993. Fungal Infections and Immune Responses. Murphy, JW. et al. (edit.). Plenum Press, NY.